Table 1. Correlation between TTN-AS1 expression and clinicopathological features in OS patients.
Characteristics | Total number | TTN-AS1 expression | P value | |
Low (n=29) | High (n=26) | |||
Age (years) | 0.651 | |||
<18 | 11 | 4 | 7 | |
≥18 | 44 | 25 | 19 | |
Gender | 0.090 | |||
Male | 36 | 16 | 20 | |
Female | 19 | 13 | 6 | |
Tumor site | 0.385 | |||
Femur/ Tibia | 18 | 11 | 7 | |
Other | 37 | 18 | 19 | |
Enneking stage | 0.041 | |||
I-II-A | 39 | 24 | 15 | |
II-B/IVB | 16 | 5 | 11 | |
Lymph node metastasis | 0.014 | |||
Absent | 47 | 28 | 19 | |
Present | 8 | 1 | 7 |